{
    "Trade/Device Name(s)": [
        "MRSA/SA ELITe MGB\u00ae"
    ],
    "Submitter Information": "ELITechGroup Epoch Biosciences",
    "510(k) Number": "K112937",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093346"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX"
    ],
    "Summary Letter Date": "May 9, 2012",
    "Summary Letter Received Date": "May 11, 2012",
    "Submission Date": "September 29, 2011",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus DNA",
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "bioM\u00e9rieux NucliSENS\u00ae easyMAG\u00ae",
        "Applied Biosystems 7500 FAST Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "Polymerase chain reaction (PCR)",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for MRSA/SA ELITe MGB\u00ae multiplex real-time PCR assay for qualitative detection of MRSA and SA DNA from nasal swabs",
    "Indications for Use Summary": "A qualitative in vitro diagnostic test for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus using DNA from nasal swabs; aids in prevention and control of MRSA infections in healthcare settings, not for diagnosis, monitoring, or susceptibility testing.",
    "fda_folder": "Microbiology"
}